✦ LIBER ✦

PCN90 Cost Effectiveness Analysis of Bendamustine as First Line Treatment for Chronic Lymphocytic Leukaemia in the Netherlands

✍ Scribed by S. Vandekerckhove; K. Holtzer-Goor; D. Van Den Steen; Y. van Megen; P. Huijgens; M. Lamotte; C. Uyl- de Groot

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN93 COST-EFFECTIVENESS ANALYSIS OF BEN

✍ J Malin; T Kongnakorn; J Sterchele; C Salvador; D Getsios; M Mwamburi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCN90 BORTEZOMIB IS COST-EFFECTIVE FOR F

✍ JB Rickert; J Hornberger; J Liwing; J Aschan; L Gjönnes; R Dhawan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN101 COST-UTILITY ANALYSIS OF DASATINI

✍ S Kuznetzov; LJ Mungapen; Y Samyshkin; DE Jakouloff; U Sbarigia; M van Baardewij 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PCN65 A COST-EFFECTIVENESS ANALYSIS OF T

✍ KK Lee; VW Lee; KC Kuok 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

PCN103 PHARMACOECONOMIC ANALYSIS OF THE

✍ F Bosch; LF Casado; JA Garcia-Marco; F Gilsanz; M Gonzalez Diaz; C Rayon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PCN71 Cost-Effectiveness Analysis of Cet

✍ V. Moreno; B. Martínez-Amores; J. Barriuso; L. Mezquita; I. Ibáñez de Cáceres; Á 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB